Taken together, our present study illustrates a novel mechanism that DDX3 epigenetically regulates a subset of tumor-suppressive miRNAs expressions to inhibit the induction of stemness in HCC (Fig. 9), which may provide helpful insights into the potential of DDX3 as a therapeutic target for elimination of hepatic CSCs. The gene discussed is DDX3X; the disease is hepatocellular carcinoma.